San Francisco, CA - 2013 Gastrointestinal Cancers Symposium - San Francisco, CA: Katsuhiko Uesaka, MD discusses Abstract 145: Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for patients with resected pancreatic cancer (JASPAC-01 study) during the Oral Abstract Session: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract at the Gastrointestinal Cancers Symposium 2013 here today, Friday January 25, 2013. The Symposium is supported by ASCO, the American Society of Clinical Oncology, ASTRO, The American Society of Radiation Oncology, SSO, Society of Surgical Oncology and the AGA Institute. Over 3,000 physicians, researchers and allied healthcare professionals are attending the meeting which is being held at the Moscone West center in San Francisco and features the latest Gastrointestinal Cancers research in the areas of basic and clinical science. Date: Friday January 25, 2013. Photo by © ASCO/Todd Buchanan 2013 Technical Questions: email@example.com; Phone: 612-226-5154.